Viewing Study NCT02141204


Ignite Creation Date: 2025-12-24 @ 9:08 PM
Ignite Modification Date: 2026-01-25 @ 6:05 AM
Study NCT ID: NCT02141204
Status: COMPLETED
Last Update Posted: 2020-12-09
First Post: 2014-05-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rotavirus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rotarix View
None HRV View
None Healthy infants View
None Liquid formulation View
None Lyophilized formulation View
None Human rotavirus vaccine View